Photo taken from Tom Powles/X
May 18, 2024, 11:30
Tom Powles: Annual meeting of the CARE 1 metastatic 1st line RCC study
Tom Powles, Director of Barts Cancer Center, shared a post on X:
“Annual meeting of the CARE 1 metastatic 1st line RCC study which is open in France and will open in UK soon.
Biomarker driven trial (PD-L1) of ipi/nivo versus VEGF/PD1.
The Barts team in Paris enjoying the sunshine!”
Source: Tom Powles/X